Meet our doctors Last reviewed: 19 Jun 2026 Sources Effectiveness of Dulaglutide in the Real World and in Special Populations of Type 2 Diabetic Patients (2020) NIH [accessed 27 January 2026] Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial (2023) The Lancet [accessed 27 January 2026] How to use Mounjaro (2023) Mounjaro [accessed 27 January 2026] Lillys SURMONT-2 results published in The Lancet show tirzepatide achieve a mean weight reduction of 15.7% at the highest dose (15mg) in adults with obesity or overweight and type 2 diabetes (2023) Lillys INVESTORS [accessed 27 January 2026] MHRA authorised diabetes drug Mounjaro (tirzepatide) for weight management and weight loss (2023) GOV.UK
Glucagon-like peptide-1 (GLP-1) receptor agonists are temperature-sensitive biological medications that require careful storage to maintain their therapeutic efficacy
Largely across society, we dont accept obesity as a long-term chronic disease, and were still looking for quick fixes and quick solutions where thats not the reality of the biology and disease process
For Indian skin tones and our climate, the goal isnt glass in the literal Korean-skin sense, but its even tone, healthy texture, and a genuine lit-from-within glow